Advertisement

Journal of Gastrointestinal Surgery

, Volume 14, Issue 3, pp 427–436 | Cite as

Lack of Correlation Between a Self-Administered Subjective GERD Questionnaire and Pathologic GERD Diagnosed by 24-h Esophageal pH Monitoring

  • Kevin Chan
  • Geoffrey Liu
  • Linda Miller
  • Clement Ma
  • Wei Xu
  • Christopher M. Schlachta
  • Gail Darling
2009 SSAT Plenary Presentation

Abstract

Introduction

Self-reported reflux symptoms do not always correspond to pathologic gastroesophageal reflux disease (GERD). We evaluated whether GERD-related symptoms in the self-reported Mayo-GERD questionnaire (GERDQ) were correlated with current gold standard definitions of pathologic GERD.

Methods

Three hundred thirty-six consecutive consenting individuals with GERD symptoms referred for 24-h esophageal pH monitoring completed a baseline GERDQ. Univariate and multivariate analyses identified questions that were most associated with percent total time pH < 4 at distal probe (DT) >4% or DeMeester score (DS) ≥14.7, two accepted definitions of pathologic GERD. A risk score was created from these analyses, followed by generation of receiver operating characteristic curves and determination of C-statistics, sensitivity, and specificities at various cut points, with prespecified minimal values of each that would be required to meet the definition of “potential clinical utility.”

Results

Forty-nine percent of patients were found to have pathologic GERD; half the patients (not necessarily those with pathologic GERD) described suffering from severe or very severe heartburn or acid regurgitation in the past year. Univariate logistic regression analysis identified six of 22 key GERD questions that were significantly related to DT or DS, in addition to age and gender. Three questions (duration of symptoms, nocturnal heartburn, hiatal hernia) along with age and gender remained significant in multivariate analyses. A risk score (RS) was created from these five questions separately for DT and DS. For DT, the C-statistic for RS was 0.75, and at the optimal cut point of ≥6 that maximizes sensitivity (SS) and specificity (SP), SS was 68% and SP was 72%. For DS, the C-statistic was 0.73, and at the optimal cut point, SS was 82% and SP 60%. When considering other cut points, the rare extreme case of very low RS (≤2) was strongly predictive of lack of pathologic GERD: for DT, SS 100%/SP 18%, negative predictive value (NPV) 100%; and for DS, SS 97%, SP 25%, NPV 88%. However, only 10–15% of patients referred for pH testing had RS scores of ≤2.

Conclusion

Self-reported prolonged history of GERD-like symptoms, nocturnal heartburn, history of a hiatus hernia, and male gender were associated with abnormal 24-h esophageal pH monitoring. However, these factors lack clinical utility to predict pathologic GERD in patients referred for pH testing. We found that 51% of patients with severe GERD symptoms do not have true pathological GERD on objective testing. The clinical implications of this study are significant in that treatment with acid-suppressing medication in such patients would be inappropriate.

Keywords

Gastroesophageal reflux disease Esophageal 24-h pH test Distal time percent DeMeester score Risk score 

Notes

Acknowledgments

We acknowledge the help and support of Jennifer Teichman, Jonathan Lui, Connor Small, and Dr Zhuo Chen.

References

  1. 1.
    McDougall NI, Johnston BT, Kee F, Collins JS, McFarland RJ, Love AH. Natural history of reflux oesophagitis: A 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38(4):481–486.CrossRefPubMedGoogle Scholar
  2. 2.
    Quigley EMM, Hungin APS. Quality-of-life issues in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22(Suppl 1):41–47. ReviewCrossRefPubMedGoogle Scholar
  3. 3.
    Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006;367:2086–2100CrossRefPubMedGoogle Scholar
  4. 4.
    Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335(8683):205–208.CrossRefPubMedGoogle Scholar
  5. 5.
    Colas-Atger E, Bonaz B, Papillon E, Gueddah N, Rolachon A, Bost R, Fournet J. Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconsistent. Dig Dis Sci 2002;47(3):645–651.CrossRefPubMedGoogle Scholar
  6. 6.
    Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995;37(4):457–464.CrossRefPubMedGoogle Scholar
  7. 7.
    Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994;69(6):539–547.PubMedGoogle Scholar
  8. 8.
    Fuchs KH, DeMeester TR, Albertucci M. Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery 1987102(4):575–580.PubMedGoogle Scholar
  9. 9.
    Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87(9):1102–1111.PubMedGoogle Scholar
  10. 10.
    Streets CG, DeMeester TR. Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do. J Clin Gastroenterol 2003;37(1):3–4.CrossRefGoogle Scholar
  11. 11.
    Schindlbeck NE, Heinrich C, König A, Dendorfer A, Pace F, Müller-Lissner SA. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterol 1987;93(1):85–90.Google Scholar
  12. 12.
    Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 1986;8(Suppl 1):52–58.PubMedCrossRefGoogle Scholar
  13. 13.
    Talley NJ, Locke GR III, McNally M, Schleck CD, Zinsmeister AR, Melton LJ III. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol 2008;103(1):12–19.CrossRefPubMedGoogle Scholar
  14. 14.
    Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28(8):681–687CrossRefPubMedGoogle Scholar
  15. 15.
    Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996;221:8–13.CrossRefPubMedGoogle Scholar
  16. 16.
    Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther 2001;15(7):981–987.CrossRefPubMedGoogle Scholar
  17. 17.
    Shaw M. Diagnostic utility of reflux disease symptoms. Gut 2004;53(Suppl IV):iv25-iv27CrossRefPubMedGoogle Scholar
  18. 18.
    Sandha GS, Hunt RH, Veldhuyzen van Zanten SJ. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and –negative non-ulcer dyspepsia. Scand J Gastroenterol 1999;34:244–249.CrossRefPubMedGoogle Scholar
  19. 19.
    Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol 2004;99(6):997–999.CrossRefGoogle Scholar
  20. 20.
    Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitatios of 24-our intraesophageal pH monitoring in the hospital setting. Gastroenterol 1985;89(4):797–804.Google Scholar
  21. 21.
    Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol 2008;43(6):654–661.CrossRefPubMedGoogle Scholar
  22. 22.
    Weigt J, Kandulski A, Büsch F, Malfertheiner P. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients. Dig Dis 2009;27(1):68–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Jenkinson LR, Norris TL, Watson A. Symptoms and endoscopic findings – can they predict abnormal nocturnal acid gastro-oesophageal reflux? Ann R Coll Surg Engl 1989;71(2):117–119.PubMedGoogle Scholar
  24. 24.
    DeMeester TR, Lafontaine E, Joelsson BE, Skinner DB, Ryan JW, O’Sullivan GC, Brunsden BS, Johnson LF. Relationship of a hiatal hernia to the function of the body of the esophagus and the gastrogesophageal junction. J Thorac Cardiovasc Surg 1981;82(4):547–558PubMedGoogle Scholar
  25. 25.
    Ter RB, Johnston BT, Castell DO. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus 1998;11(2):106–108.PubMedGoogle Scholar
  26. 26.
    Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992;37(6):849–856.CrossRefPubMedGoogle Scholar
  27. 27.
    Fass R, Sampliner RE, Mackel C, McGee D, Rappaport W. Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects. Dig Dis Sci 1993;38(10):1926–1928.CrossRefPubMedGoogle Scholar
  28. 28.
    Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G. Features of gastroesophageal reflux disease in women. Am J Gastroenterol 2004;99(8):1442–1447.CrossRefPubMedGoogle Scholar
  29. 29.
    Richter JE, DeMeester TR. Gender but not age affects normal 24-hour esophageal pH values. Am J Gastroenterol 1990;85:A1224.Google Scholar
  30. 30.
    Andersen LI, Madsen PV, Dalgaard P, Jensen G. Validity of clinical symptoms in benign esophageal disease assessed by questionnaire. Acta Med Scand 1987;221(2):171–177.PubMedGoogle Scholar
  31. 31.
    Shimoyama Y, Kusano M, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Moki F, Sugiyama T, Toki M, Ohwada T, Mori M. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol 2005;20(4):643–647.CrossRefPubMedGoogle Scholar
  32. 32.
    Kusano M, Ino K, Yamada T. Interoobserver and intraobserver variation in endoscopic assessment of GERD using the Los Angeles classification. Gastrointest Endosc 1999;49(6):700–704CrossRefPubMedGoogle Scholar
  33. 33.
    McColl E, Junghard O, Wiklund I, Revicki DA. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians’ assessments agree with those of their patients? Am J Gastroenterol 2005;100:11–18CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2010

Authors and Affiliations

  • Kevin Chan
    • 1
  • Geoffrey Liu
    • 1
  • Linda Miller
    • 2
  • Clement Ma
    • 3
  • Wei Xu
    • 3
  • Christopher M. Schlachta
    • 4
  • Gail Darling
    • 2
  1. 1.Department of Medical Biophysics and MedicinePrincess Margaret Hospital/Ontario Cancer InstituteTorontoCanada
  2. 2.Department of Surgery (Thoracic Surgery), Toronto General HospitalUniversity of TorontoTorontoCanada
  3. 3.Biostatistics DepartmentPrincess Margaret Hospital/Ontario Cancer InstituteTorontoCanada
  4. 4.Department of SurgeryUniversity of Western OntarioLondonCanada

Personalised recommendations